Specific reduction of BIRC6 expression by siRNAs led to a marked inhibition of prostate cancer cell viability (Fig. 3, S2), which notably was coupled to a marked increase in Annexin-V positive cells and the expression of apoptosis markers (Fig. 4A, B). The gene discussed is ANXA5; the disease is prostate cancer.